Efficacy of ayurvedic treatment protocol in the Management of Asrigdara (Abnormal Uterine Bleeding): An Open Labelled Single Arm Clinical Trial

Efficacy of Indrayavadi Yoga and Shatavari Taila Matrabasti in the Management of Asrigdara (Abnormal Uterine Bleeding): An Open Labelled Single Arm Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/02/040541

Enrollment

Registered

2022-02-23

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Both married and unmarried womens having classical features of asrigdara between age group 18-45 years. Patient presenting with any one of the classical features will be included in study.

Exclusion criteria

Exclusion criteria: age below 18 and above 45 years, bleeding due to cervical erosion, carcinoma, fibroids and polyp, bleeding following abortion, bleeding from any site other than uterus, blood coagulation disorders,post menopausal bleeding , hb <7gm%

Design outcomes

Primary

Measure	Time frame
It is expected that the trial drug will help in normalization of menstrual cycle.Timepoint: 4Months	—

Secondary

Measure	Time frame
Not applicableTimepoint: Not applicable	—

Countries

India

Contacts

Public ContactDr Sipika Swati

Institute Of Teaching and Research in Ayurveda

drsipikaswatibhu@gmail.com9889501569

Outcome results